Next Biomedical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 29, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	488,131	733,427	331,554	-	-	-
Market Cap Growth	43.18%	121.21%	-	-	-	-
Enterprise Value	458,845	714,251	316,300	-	-	-
Last Close Price	59500.00	89400.00	41000.00	-	-	-
PE Ratio	-	-	115.95	-	-	-
PS Ratio	29.63	44.51	34.74	-	-	-
PB Ratio	10.15	15.25	7.34	-	-	-
P/TBV Ratio	10.21	15.35	7.39	-	-	-
P/OCF Ratio	390.47	586.68	-	-	-	-
EV/Sales Ratio	27.85	43.35	33.15	-	-	-
Debt / Equity Ratio	0.16	0.16	0.24	0.70	0.56	6.25
Net Debt / Equity Ratio	-0.61	-0.61	-0.68	-0.17	-0.19	1.92
Net Debt / EBITDA Ratio	145.67	145.67	9.95	0.58	0.71	-1.49
Net Debt / FCF Ratio	15.40	15.40	18.70	0.66	0.45	-1.60
Asset Turnover	0.28	0.28	0.22	0.16	0.08	0.07
Inventory Turnover	1.79	1.79	1.60	1.37	1.61	1.83
Quick Ratio	4.89	4.89	3.68	1.35	1.38	1.70
Current Ratio	5.38	5.38	3.95	1.57	1.59	1.82
Return on Equity (ROE)	-0.67%	-0.67%	9.28%	-41.64%	-46.30%	-
Return on Assets (ROA)	-0.76%	-0.76%	-5.05%	-10.57%	-10.03%	-13.55%
Return on Capital Employed (ROCE)	-1.40%	-1.40%	-7.60%	-28.70%	-27.30%	-26.10%
Earnings Yield	-0.06%	-0.04%	0.86%	-	-	-
FCF Yield	-0.39%	-0.26%	-0.50%	-	-	-
Buyback Yield / Dilution	-13.65%	-13.65%	-14.72%	-1.10%	-28.34%	-13.05%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.